Pfizer announced it is ending its development of its experimental oral GLP-1 drug to treat obesity, the company said on Monday, after a patient in a trial suffered a liver injury potentially caused by the experimental drug known as danuglipron.
Read More Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage FearsTag: Clinical trial
Exclusive: Musk’s Neuralink brain implant company cited by FDA over animal lab issues
FDA inspectors uncover quality control issues at Neuralink’s animal research facility.
Read More Exclusive: Musk’s Neuralink brain implant company cited by FDA over animal lab issuesThousands Express Interest In Volunteering To Receive Musk’s Neuralink Microchip
Thousands volunteer for Elon Musk’s Neuralink microchip brain implant study.
Read More Thousands Express Interest In Volunteering To Receive Musk’s Neuralink Microchip